VTAK Stock Analysis: Buy, Sell, or Hold?
VTAK - Catheter Precision, Inc.
$0.92
0.05 (5.78%)
β²
5d:
-12.38%
30d:
+15.77%
90d:
-22.69%
WAIT
LOW Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 10, 2026
Get Alerted When VTAK Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
βΈοΈ WAIT FOR STABILIZATION: VTAK is down 12.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
βΈοΈ WAIT FOR STABILIZATION: VTAK is down 12.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: VTAK is currently trading at $0.92, which is considered fair relative to its 30-day fair value range of $0.84 to $1.02.
Technical Outlook: Technically, VTAK is in a strong downtrend. Immediate support is located at $0.81, while resistance sits at $1.09. The stock is showing strong short-term momentum, up 5.8% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.00 (+117.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, VTAK is in a strong downtrend. Immediate support is located at $0.81, while resistance sits at $1.09. The stock is showing strong short-term momentum, up 5.8% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.00 (+117.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.84 -
$1.02
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
80.0%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.8%)
- BULLISH: Trading 117.4% below Wall St target ($2.00)
- WARNING: Recommendation downgraded due to -12.4% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$0.84 -
$1.02
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.81
Resistance Level
$1.09
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.88
Wall Street Target
$2.00
(+117.4%)
Revenue Growth (YoY)
202.1%
Share & Embed Analysis
Last updated: June 24, 2026 8:57 AM ET
Data refreshes hourly during market hours. Next update: 9:57 AM
Data refreshes hourly during market hours. Next update: 9:57 AM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VTAK showing a specific setup today?
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$77 | 60 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 57 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 61 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$242 | 61 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 56 HOLD |